Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|September 14, 2024
Nanotechnology Advances in the Detection and Treatment of Lymphoid MalignanciesFrancesco Maria Adamo, Filomena De Falco, Erica Dorillo, et al.
Cancer Treatment Reviews|November 5, 2013
Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunitiesAngela Esposito, Alberto Bardelli, Carmen Criscitiello, et al.
Critical Reviews in Oncology/Hematology|October 2, 2023
The CDK4/6 inhibitors biomarker landscape: The most relevant biomarkers of response or resistance for further research and potential clinical utilityGabriele Antonarelli, Beatrice Taurelli Salimbeni, Antonio Marra, et al.
Expert Opinion on Pharmacotherapy|June 5, 2020
Pharmacological management of male breast cancerBruno A Duso, Dario Trapani, Antonio Marra, et al.
Cancer Treatment Reviews|September 21, 2015
Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonistAngela Esposito, Carmen Criscitiello, Lucia Gelao, et al.
Autopsy & Case Reports|June 6, 2017
Cat-scratch disease presenting as multiple hepatic lesions: case report and literature reviewMariana Andrade Baptista, Denise Swei Lo, Noely Hein, et al.
The Breast Journal|July 26, 2012
Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort reportGaetano Aurilio, Elisabetta Munzone, Edoardo Botteri, et al.
Immunotherapy|April 26, 2014
Dendritic cell-based vaccines: clinical applications in breast cancerLucia Gelao, Carmen Criscitiello, Angela Esposito, et al.
Breast (Edinburgh, Scotland)|January 18, 2025
Advancing treatment choices: CDK4/6 inhibitor switching in HR+/HER2- metastatic breast cancerPaola Zagami, Angela Esposito, Beatrice Taurelli Salimbeni, et al.
Cancer Letters|January 30, 2017
Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trialEmilia Montagna, Antonella Palazzo, Patrick Maisonneuve, et al.
Pageof 8